Ariad Pharmaceuticals Inc fka ARIA

[glass_half_full]

shockingly careless

Careless, yes. Shocking? Well, perhaps I'm cynical, but the truth is that sell-side analysis is just not that great.

Real buy-side analysis is thorough, expensive, actionable and closely guarded.

As for Illverson, I agree that his value, while perhaps non-pecuniary in nature, is positive.

And Cramer's short-attention-span-theatre is basically the distracting shill for the HFT algos and market makers who pick the pockets of over-active traders.

As far as smart people making poor decisions, perhaps "Stupid is as stupid does."